Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 329
7
Diseases
10
Unique genes
0.282
Avg. similarity score
Intellectual development disorder, truncal obesity, retinal dystrophy, and micropenis
Most-connected disease (5 links)
Disease
Searched: Intellectual development disorder, truncal obesity, retinal dystrophy, and micropenis
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Intellectual development disorder, truncal obesity, retinal dystrophy, and micropenis
Joubert syndrome 1
Mental retardation, truncal obesity, retinal dystrophy, and micropenis
Congenital hemivertebra
Coach syndrome
Congenital hypoplasia of femur
Ficus syndrome
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Intellectual development disorder, truncal obesity, retinal dystrophy, and micropenis | 5 | 5 | 1 |
| Joubert syndrome 1 | 5 | 5 | 1 |
| Mental retardation, truncal obesity, retinal dystrophy, and micropenis | 5 | 5 | 1 |
| Congenital hemivertebra | 4 | 4 | 5 |
| Coach syndrome | 3 | 3 | 5 |
| Congenital hypoplasia of femur | 3 | 3 | 2 |
| Ficus syndrome | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| INPP5E | 6 / 7 | Coach syndrome, Congenital hemivertebra, Congenital hypoplasia of femur, Intellectual development disorder, truncal obesity, retinal dystrophy, and micropenis and 2 more |
| LSM1 | 2 / 7 | Congenital hemivertebra, Ficus syndrome |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Anchoring of the basal body to the plasma membrane | Reactome | 4 / 98 | 49.0× | 8.43e-7 | 3.59e-5 ✓ sig. |
| Hedgehog 'off' state | Reactome | 2 / 56 | 42.9× | 9.38e-4 | 1.08e-2 ✓ sig. |
| ARL13B-mediated ciliary trafficking of INPP5E | Reactome | 1 / 3 | 400× | 2.50e-3 | 2.23e-2 ✓ sig. |
| mRNA decay by 5' to 3' exoribonuclease | Reactome | 1 / 14 | 85.8× | 1.16e-2 | 6.22e-2 |
| Synthesis of PIPs at the Golgi membrane | Reactome | 1 / 18 | 66.7× | 1.49e-2 | 7.22e-2 |
| VxPx cargo-targeting to cilium | Reactome | 1 / 21 | 57.2× | 1.74e-2 | 7.88e-2 |
| Notch signaling pathway | KEGG | 1 / 62 | 19.4× | 5.05e-2 | 1.46e-1 |
| Lysine degradation | KEGG | 1 / 63 | 19.1× | 5.13e-2 | 1.47e-1 |
| Collagen biosynthesis and modifying enzymes | Reactome | 1 / 67 | 17.9× | 5.44e-2 | 1.52e-1 |
| Loss of Nlp from mitotic centrosomes | Reactome | 1 / 70 | 17.2× | 5.68e-2 | 1.56e-1 |
| Loss of proteins required for interphase microtubule organization from the centrosome | Reactome | 1 / 70 | 17.2× | 5.68e-2 | 1.56e-1 |
| Inositol phosphate metabolism | KEGG | 1 / 73 | 16.5× | 5.92e-2 | 1.59e-1 |
| AURKA Activation by TPX2 | Reactome | 1 / 73 | 16.5× | 5.92e-2 | 1.59e-1 |
| RNA degradation | KEGG | 1 / 78 | 15.4× | 6.31e-2 | 1.65e-1 |
| Recruitment of mitotic centrosome proteins and complexes | Reactome | 1 / 82 | 14.6× | 6.62e-2 | 1.70e-1 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| cilium assembly | GO:0060271 | 5 / 237 | 39.4× | 7.53e-8 | 1.00e-5 ✓ sig. |
| kidney development | GO:0001822 | 3 / 146 | 38.4× | 5.39e-5 | 1.95e-3 ✓ sig. |
| axoneme assembly | GO:0035082 | 2 / 33 | 113× | 1.35e-4 | 3.83e-3 ✓ sig. |
| cell projection organization | GO:0030030 | 3 / 214 | 26.2× | 1.67e-4 | 4.47e-3 ✓ sig. |
| non-motile cilium assembly | GO:1905515 | 2 / 57 | 65.6× | 4.05e-4 | 8.24e-3 ✓ sig. |
| metanephric distal tubule morphogenesis | GO:0072287 | 1 / 1 | 1,869× | 5.35e-4 | 9.88e-3 ✓ sig. |
| camera-type eye development | GO:0043010 | 2 / 74 | 50.5× | 6.82e-4 | 1.17e-2 ✓ sig. |
| determination of left/right symmetry | GO:0007368 | 2 / 83 | 45.0× | 8.57e-4 | 1.33e-2 ✓ sig. |
| liver development | GO:0001889 | 2 / 87 | 43.0× | 9.41e-4 | 1.42e-2 ✓ sig. |
| nitrogen cycle metabolic process | GO:0071941 | 1 / 2 | 934× | 1.07e-3 | 1.51e-2 ✓ sig. |
| hydroxylysine biosynthetic process | GO:0046947 | 1 / 2 | 934× | 1.07e-3 | 1.51e-2 ✓ sig. |
| negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation | GO:2000314 | 1 / 2 | 934× | 1.07e-3 | 1.51e-2 ✓ sig. |
| lymph vessel morphogenesis | GO:0036303 | 1 / 3 | 623× | 1.60e-3 | 1.88e-2 ✓ sig. |
| metanephric proximal tubule development | GO:0072237 | 1 / 3 | 623× | 1.60e-3 | 1.88e-2 ✓ sig. |
| negative regulation of protein localization to cilium | GO:1903565 | 1 / 3 | 623× | 1.60e-3 | 1.88e-2 ✓ sig. |